Caldiamide sodium
CAS: 131410-50-9
Ref. 3D-GFA41050
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire | ||
500mg | To inquire |
Product Information
- 2,5,8,11-Tetraazatridecan-13-oic acid, 5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-, calcium complex
- Calciate(1-), [5,8-bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)]-, sodium
- Calciate(1-), [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-κN<sup>5</sup>,κN<sup>8</sup>,κN<sup>11</sup>,κO<sup>13</sup>]-, sodium
- Calciate(1-), [5,8-bis[(carboxy-κO)methyl]-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-)-κN<sup>5</sup>,κN<sup>8</sup>,κN<sup>11</sup>,κO<sup>13</sup>]-, sodium (1:1)
- Calcium Sodium 5,8-Bis(Carboxylatomethyl)-11-[2-(Methylamino)-2-Oxoethyl]-3-Oxo-2,5,8,11-Tetraazatridecan-13-Oate (1:1:1) (Non-Preferred Name)
- Ccris 6697
- Dv-7572
Caldiamide sodium is a soluble organic solvent that has been used in targeted drug delivery. It has been shown to be effective in the treatment of glomerulopathy, with a dose-dependent reduction in proteinuria and regression of renal lesions. Caldiamide sodium may also have therapeutic potential for the treatment of other conditions, such as lupus nephritis, where it may modulate the immune system. The mechanism of action is not fully understood but is thought to involve metal chelate modulation and/or intra-articular injection.
Chemical properties
Technical inquiry about: 3D-GFA41050 Caldiamide sodium
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.